Johnson & Johnson's agreement with the Trump administration enables patients to access drugs at a comparable price to other ...

aims to advance oncology research by integrating computational design, medicinal chemistry, biology, medical science and ...

Aragen's new cell line development and early manufacturing platform, CHOMax, can cut timelines to approximately 10 months.

Codexis Inc. and Axolabs have entered into an agreement under which Axolabs will evaluate Codexis’ ECO Synthesis ...

Rentschler to manufacture VarmX’s VMX-C001 for Phase 3 development and potential commercialization.

Eli Lilly and Company has entered a definitive agreement to acquire Ventyx Biosciences Inc., a San Diego-based clinical-stage ...

Sharp Sterile Manufacturing is investing $28 million to expand its site in Lee, Massachusetts, which offers a range of ...

AstraZeneca has named Rick R. Suarez as Senior Vice President, U.S. President and Head of the U.S. Biopharmaceuticals ...

Patient access to innovative new therapies requires us to reimagine the supply chain and how it integrates advanced ...

ProBioGen has signed a Master Service Agreement with Zag Bio Inc., a biotechnology company developing thymus-targeted ...

GeneDx, a rare disease diagnosis company, has appointed Linda Genen, MD, MPH as Chief Medical Officer to strengthen the ...

Evotec SE’s Seattle-based subsidiary, Just – Evotec Biologics Inc., has received a new grant from the Gates Foundation to ...